SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-19-000067
Filing Date
2019-11-06
Accepted
2019-11-06 17:15:37
Documents
83
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q heska-09302019x10q.htm 10-Q 1507812
2 EXHIBIT 31.1 heska-09302019xex31x1.htm EX-31.1 12440
3 EXHIBIT 31.2 heska-09302019xexx31x2.htm EX-31.2 12651
4 EXHIBIT 32.1 heska-09302019xex32x1.htm EX-32.1 9298
11 heskalogowhtbkgd09.jpg GRAPHIC 53004
  Complete submission text file 0001038133-19-000067.txt   7945096

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hska-20190930.xml EX-101.INS 1696641
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20190930.xsd EX-101.SCH 51103
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20190930_cal.xml EX-101.CAL 105613
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20190930_def.xml EX-101.DEF 276695
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20190930_lab.xml EX-101.LAB 785536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20190930_pre.xml EX-101.PRE 449678
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 191197229
SIC: 2835 In Vitro & In Vivo Diagnostic Substances